Company: LPSN
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001102993-25-000187
Chunk: 84

Company: LIVEPERSON INC
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 84
---
 to acquire common stock granted under the 2019 Stock Incentive Plan have four-year terms. As of September 30, 2025, 104,836 shares of common stock remained available for issuance (taking into account all stock option exercises and other equity award settlements through September 30, 2025). Employee Stock Purchase PlanThe number of shares authorized for issuance under the ESPP as of September 30, 2025, was 300,000 shares. As of September 30, 2025, 162,658 shares of common stock remained available for issuance under the ESPP (taking into account all share purchases through September 30, 2025).Inducement PlanThere are 1,027,489 shares of common stock authorized and reserved for issuance under the Inducement Plan. As of September 30, 2025, 69,364 shares of common stock remained available for issuance under the Inducement Plan (taking into account all option exercises and other equity award settlements through September 30, 2025). CEO Inducement AwardAs part of an equity compensation package negotiated to induce John Sabino, the Company’s Chief Executive Officer, to accept employment with the Company, pursuant to the terms of the employment agreement entered into between Mr. Sabino and the Company, the Company granted Mr. Sabino an option to purchase 66,666 shares of common stock (the “CEO Inducement Award”) that will vest upon the satisfaction of certain performance-based and time-based vesting conditions. On May 17, 2024, the Company’s board of directors authorized 66,666 shares for issuance under the CEO Inducement Award in compliance with and in reliance on Nasdaq Listing Rule 5635(c)(4). The CEO Inducement Award was a standalone award granted outside of the 2019 Stock Incentive Plan and 2018 Inducement Plan.

32

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(UNAUDITED)

Stock Option ActivityThe following table is a summary of the Company’s stock option activity and weighted average exercise prices for the nine months ended September 30, 2025:Stock Option ActivityWeighted Average Remaining Contractual Term (In years)Aggregate Intrinsic Value (In thousands)Options (In thousands)WeightedAverageExercise PriceBalance outstanding at December 31, 2024178 $343.95 3.95$7 Granted 27 16.20 Cancelled